E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 3.874 EUR 1.1%
Market Cap: 369m EUR
Have any thoughts about
Euroapi SAS?
Write Note

Operating Margin
Euroapi SAS

0.4%
Current
1%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0.4%
=
Operating Profit
4.3m
/
Revenue
971.3m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
FR
Euroapi SAS
PAR:EAPI
369m EUR
0%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-83%
US
Eli Lilly and Co
NYSE:LLY
749.7B USD
35%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK
44%
US
Johnson & Johnson
NYSE:JNJ
372B USD
28%
US
Merck & Co Inc
NYSE:MRK
257.3B USD
34%
CH
Roche Holding AG
SIX:ROG
201.7B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
163B GBP
21%
CH
Novartis AG
SIX:NOVN
179.6B CHF
31%
US
Pfizer Inc
NYSE:PFE
146B USD
22%
Country FR
Market Cap 369m EUR
Operating Margin
0%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 749.7B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.3T DKK
Operating Margin
44%
Country US
Market Cap 372B USD
Operating Margin
28%
Country US
Market Cap 257.3B USD
Operating Margin
34%
Country CH
Market Cap 201.7B CHF
Operating Margin
32%
Country UK
Market Cap 163B GBP
Operating Margin
21%
Country CH
Market Cap 179.6B CHF
Operating Margin
31%
Country US
Market Cap 146B USD
Operating Margin
22%
No Stocks Found

Euroapi SAS
Glance View

Market Cap
369m EUR
Industry
Pharmaceuticals

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

EAPI Intrinsic Value
4.229 EUR
Undervaluation 8%
Intrinsic Value
Price
E

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0.4%
=
Operating Profit
4.3m
/
Revenue
971.3m
What is the Operating Margin of Euroapi SAS?

Based on Euroapi SAS's most recent financial statements, the company has Operating Margin of 0.4%.